SCHEMBL9685579

SCHEMBL9685579

CCc1ccccc1OCCOS(C)(=O)=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.64
MAPT P10636 2/20 0.64
NPSR1 Q6W5P4 1/20 0.64
HPGD P15428 2/20 0.51
ATM Q13315 1/20 0.51
KDM4E B2RXH2 4/20 0.51
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
NISCH Q9Y2I1 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HTT P42858 2/20 0.39
DRD2 P14416 2/20 0.39
DRD1 P21728 2/20 0.39
DRD3 P35462 1/20 0.39
TSHR P16473 2/20 0.38
HSD17B10 Q99714 1/20 0.38
ALOX15 P16050 2/20 0.38
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10783529 0.85 L3MBTL1 (0.84) L3MBTL1MAPTNPSR1HPGDATM
SCHEMBL2345631 0.84 L3MBTL1 (0.61) L3MBTL1MAPTNPSR1HPGDATM
SCHEMBL9262266 0.83 CYP1A2 (0.51) L3MBTL1MAPTNPSR1HPGDATM
SCHEMBL5657713 0.82 L3MBTL1 (0.46) L3MBTL1MAPTNPSR1HPGDATM
SCHEMBL9270489 0.81 L3MBTL1 (0.43) L3MBTL1MAPTNPSR1HPGDKDM4E
SCHEMBL6274367 0.81 TDP1 (0.48) L3MBTL1MAPTNPSR1HPGDKDM4E
SCHEMBL6275145 0.81 LMNA (0.53) L3MBTL1MAPTNPSR1KDM4ESMN1; SMN2
SCHEMBL15923458 0.80 LMNA (0.51) L3MBTL1MAPTNPSR1KDM4EMEN1
SCHEMBL4860922 0.80 L3MBTL1 (0.56) L3MBTL1MAPTNPSR1HPGDATM
SCHEMBL7215472 0.80 MAPT (0.44) L3MBTL1MAPTNPSR1HPGDATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166218-A Antilipemic agents or antiglycemic agents HOFFMANN-LA ROCHE INC. (US) 1992-11-24 US disclosed
US-5064863-A Catabolic activity, obesity, diabetes HOFFMANN-LA ROCHE INC. (US) 1991-11-12 US disclosed